Related references
Note: Only part of the references are listed.After 6 years with Xolair; a 3-year withdrawal follow-up
A. Nopp et al.
ALLERGY (2010)
Eosinophils in bronchial mucosa of asthmatics after allergen challenge: effect of anti-IgE treatment
E. L. J. van Rensen et al.
ALLERGY (2009)
Baseline characteristics of patients enrolled in EXCELS: a cohort study
Aidan A. Long et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2009)
Safety and tolerability of omalizumab
J. Corren et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2009)
Vaccines targeting IgE in the treatment of asthma and allergy
Zhikang Peng
HUMAN VACCINES (2009)
Prostaglandin H-2 induces the migration of human eosinophils through the chemoattractant receptor homologous molecule of Th2 cells, CRTH2
Rufina Schuligoi et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Pulmonary fibrosis: pathogenesis, etiology and regulation
M. S. Wilson et al.
MUCOSAL IMMUNOLOGY (2009)
Budesonide/formoterol decreases expression of vascular endothelial growth factor (VEGF) and VEGF receptor 1 within airway remodelling in asthma
Ke Wang et al.
ADVANCES IN THERAPY (2008)
Anti-proliferative and anti-remodelling effect of beclomethasone dipropionate, formoterol and salbutamol alone or in combination in primary human bronchial fibroblasts
D. Descalzi et al.
ALLERGY (2008)
A high-affinity monoclonal anti-IgE antibody for depletion of IgE and IgE-bearing cells
S. Laffer et al.
ALLERGY (2008)
Transforming growth factor-β regulates house dust mite-induced allergic airway inflammation but not airway remodeling
Rannzi Fattouh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
IgE alone promotes human lung mast cell survival through the autocrine production of IL-6
Glenn Cruse et al.
BMC IMMUNOLOGY (2008)
A new paradigm of eosinophil granulocytes: neuroimmune interactions
Ulrike Raap et al.
EXPERIMENTAL DERMATOLOGY (2008)
The development of allergic inflammation
Stephen J. Galli et al.
NATURE (2008)
Reduced Lung Function in a Chronic Asthma Model Is Associated with Prolonged Inflammation, but Independent of Peribronchial Fibrosis
Cordula Koerner-Rettberg et al.
PLOS ONE (2008)
Prolonged eosinophil production after allergen exposure in IFN-γR KO mice is IL-5 dependent
L. -L. Zhao et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2008)
Treatment strategies for allergy and asthma
Stephen T. Holgate et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Delayed onset and protracted progression of anaphylaxis after omalizumab administration in patients with asthma
Susan L. Limb et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Asthma therapy and airway remodeling
Thais Mauad et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
CD-sens and clinical changes during withdrawal of Xolair after 6 years of treatment
A. Nopp et al.
ALLERGY (2007)
Clinical relevance of airway remodelling in airway diseases
A. L. James et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Connective tissue growth factor expression is regulated by histamine in lung fibroblasts: Potential role of histamine in airway remodeling
Steffen Kunzmann et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Eosinophils: Singularly destructive effector cells or purveyors of immunoregulation?
Elizabeth A. Jacobsen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Specificity of basement membrane thickening in severe asthma
Arnaud Bourdin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Eosinophils in the pathogenesis of allergic airways disease
S. G. Trivedi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Allergen-induced airway remodelling
C. M. Lloyd et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
IL-13 and epidermal growth factor receptor have critical but distinct roles in epithelial cell mucin production
Guohua Zhen et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
Safety of anti-immunoglobulin E therapy with omalizumab in allergic patients at risk of geohelminth infection
A. A. Cruz et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2007)
Nonpharmacological and pharmacological interventions to prevent or reduce airway remodelling
E. H. Walters et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Airway remodelling in asthma: Current understanding and implications for future therapies
Mimi L. K. Tang et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade
WR Henderson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Inter-relationships between airway inflammation, reticular basement membrane thickening and bronchial hyper-reactivity to methacholine in asthma; a systematic bronchoalveolar lavage and airway biopsy analysis
C Ward et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2005)
Connective tissue growth factor: A role in airway remodelling in asthma?
JK Burgess
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2005)
Effects of omalizumab and budesonide on markers of inflammation in human bronchial epithelial cells
YC Huang et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2005)
Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects
JA Poole et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
The role of eosinophils in the pathogenesis of asthma
AB Kay
TRENDS IN MOLECULAR MEDICINE (2005)
Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment):: INNOVATE
M Humbert et al.
ALLERGY (2005)
The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation
S Holgate et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Airway remodelling and inflammation in sheep lungs after chronic airway challenge with house dust mite
KJ Snibson et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2005)
Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma
ST Holgate et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2004)
The effect of eosinophils on collagen gel contraction and implications for tissue remodelling
U Zagai et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Bronchoalveolar lavage fluid concentrations of transforming growth factor (TGF)-β1, TGF-β2, interleukin (IL)-4 and IL-13 after segmental allergen challenge and their effects on α-smooth muscle actin and collagen III synthesis by primary human lung fibroblasts
V Batra et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2004)
Prolonged allergen challenge in mice leads to persistent airway remodelling
SJ Mcmillan et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2004)
Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma
R Djukanovic et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Differences in airway remodeling between asthma and chronic obstructive pulmonary disease
K Aoshiba et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2004)
Role of interleukin-5 and eosinophils in allergen-induced airway remodeling in mice
H Tanaka et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2004)
Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate-to-severe) allergic asthma
JG Ayres et al.
ALLERGY (2004)
Increase in laminin expression in allergic airway remodelling and decrease by dexamethasone
PE Christie et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Reversibility of airway inflammation and remodelling following cessation of antigenic challenge in a model of chronic asthma
RK Kumar et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2004)
Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression
PG Woodruff et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Human dendritic cell 1 and dendritic cell 2 subsets express FcεF-RI:: Correlation with serum IgE and allergic asthma
B Foster et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Regulation of procollagen I (α1) by interleukin-4 in human bronchial fibroblasts:: a possible role in airway remodelling in asthma
C Bergeron et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2003)
Allergic and nonallergic forms of atopic diseases
N Novak et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Airway structural alterations selectively associated with severe asthma
L Benayoun et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Mast cells play a partial role in allergen-induced subepithelial fibrosis in a murine model of allergic asthma
T Masuda et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2003)
Dissociation of T helper type 2 cytokine-dependent airway lesions from signal transducer and activator of transcription 6 signalling in experimental chronic asthma
PS Foster et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2003)
Interleukin-9 induces goblet cell hyperplasia during repair of human airway epithelia
PD Vermeer et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2003)
Pharmacotherapy and airway remodelling in asthma?
PA Beckett et al.
THORAX (2003)
Increased expression of p21(waf) cyclin-dependent kinase inhibitor in asthmatic bronchial epithelium
SM Puddicombe et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2003)
The involvement of matrix metalloproteinases in basement membrane injury in a murine model of acute allergic airway inflammation
K Kumagai et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2002)
Effect of ozone and nitrogen dioxide on the permeability of bronchial epithelial cell cultures of non-asthmatic and asthmatic subjects
H Bayram et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2002)
Asthmatic bronchial epithelium is more susceptible to oxidant-induced apoptosis
F Bucchieri et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)
Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma
R Buhl et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma
C Ward et al.
THORAX (2002)
A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model
WR Henderson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Remodeling of the airway epithelium in asthma
JV Fahy
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
W Busse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics
M Solèr et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
Airway smooth muscle cell proliferation is increased in asthma
PRA Johnson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
IL-5 deficiency abolishes aspects of airway remodelling in a murine model of lung inflammation
A Trifilieff et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2001)
Expression of the high-affinity IgE receptor on peripheral blood dendritic cells: Differential binding of IgE in atopic asthma
JA Holloway et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Fluticasone inhibits but does not reverse allergen-induced structural airway changes
NJ Vanacker et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Relationship of epidermal growth factor receptors to goblet cell production in human bronchi
K Takeyama et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Advances in immunology - Allergy and allergic diseases - First of two parts
AB Kay
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Biopsy markers of airway inflammation and remodelling
PK Jeffery et al.
RESPIRATORY MEDICINE (2000)
In vitro IgE inhibition in B cells by anti-CD23 monoclonal antibodies is functionally dependent on the immunoglobulin Fc domain
T Nakamura et al.
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY (2000)
Share Paper
